LEADING PHARMA
Live / Registered — Registered and renewed (as of 12 Feb 2026)
What this means for you
Registered since 18 Oct 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Oct 2026).
Record
- Serial number
- 86927234
- Registration number
- 5062963
- Mark type
- Word mark
- Filed
- 03 Mar 2016
- Published for opposition
- 02 Aug 2016
- Registered
- 18 Oct 2016
- Next maintenance due
- 18 Oct 2026
- Attorney of record
- Mary L. Grieco
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological disorders, heart disease, liver disease, kidney disease, digestive disorders, blood disorders, high blood pressure, depression, anxiety, and obesity; Vitamin and mineral supplements
Owner
- Leading Pharma, LLC, Fairfield, NJ, US
- Leading Pharma, LLC, Fairfield, NJ, US
- Leading Pharma, LLC, Fairfield, NJ, US
Prosecution history
- 12 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Feb 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Feb 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Nov 2025 — TEAS SECTION 8 & 9 RECEIVED
- 18 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Apr 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Oct 2021 — TEAS SECTION 8 & 15 RECEIVED
- 18 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
- 02 Aug 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Aug 2016 — PUBLISHED FOR OPPOSITION
- 13 Jul 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED